18 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Design, synthesis, and structure-activity relationships of tetrahydroquinoline-based farnesyltransferase inhibitors.
Bristol-Myers Squibb Pharmaceutical Research Institute
Modeling of binding modes and inhibition mechanism of some natural ligands of farnesyl transferase using molecular docking.
University of Milan
Successful virtual screening of a chemical database for farnesyltransferase inhibitor leads.
Mayo Medical School and Mayo Clinic
Structure-activity relationships of cysteine-lacking pentapeptide derivatives that inhibit ras farnesyltransferase.
Warner-Lambert
Constrained analogs of KCVFM with improved inhibitory properties against farnesyl transferase
TBA
Peptide based P21RAS farnesyl transferase inhibitors: systematic modification of the tetrapeptide CA1A2X motif
TBA
Evaluation of amino acid-based linkers in potent macrocyclic inhibitors of farnesyl-protein transferase.
Merck Research Laboratories
Discovery of a series of cyclohexylethylamine-containing protein farnesyltransferase inhibitors exhibiting potent cellular activity.
Abbott Laboratories
Solid-phase synthesis of novel inhibitors of farnesyl transferase.
Institute of Cancer Research
A new class of highly potent farnesyl diphosphate-competitive inhibitors of farnesyltransferase.
Tsukuba Research Institute
C-terminal modifications of histidyl-N-benzylglycinamides to give improved inhibition of Ras farnesyltransferase, cellular activity, and anticancer activity in mice.
Warner-Lambert
Novel benzimidazole phosphonates as potential inhibitors of protein prenylation.
University of Iowa
2-substituted piperazines as constrained amino acids. Application to the synthesis of potent, non carboxylic acid inhibitors of farnesyltransferase.
Merck Research Laboratories